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The sulphydryl reagent thimerosal (50/~M) released Ca '+ from a non-mitoehondrial intraeellalar Ca:" pool in a dose.dependent manner in 
pgrmeabilizoa insalin-~ceretin 8 RINmSF cells. Thi~ release was reversed after addition of the reducing agent dithiothreitol. Ca:" was releas,,M from 
an Ins(l.4,5)P;-insensitive pool, since release was observed even after depletion of the lns(I,4,5)P~-sensitive pool by a supramaximal dose of 
lns(2.4,5)P~ or thapsigargin. The lns(I.4,5)P~-sensitive pool remained essentially unaltered by thimerosal. Thimero~al.induced Ca :~ release was 
potentiated bycaffeine. These findings suggest the existence ofCa"*-induced Ca:" release also in insulin-secreting cells. 
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1. INTRODUCTION 
In many cells, including insulin-secreting cells, re- 
ceptor activation leads to phospholipase-C mediated 
hydrolysis of phosphatidylinositol 4,5-bisphosphate, r -
suiting in generation of diacylglycerol and inositol 
1,4,5-trisphosphate, (lns(1,4,5)P~)[l-3]. Ins(l,4,5)P3 is a 
well-known second messenger that mobilizes Ca 2+ from 
specific intracelhtlar stores, which appear to be struc- 
turally related to the endoplasmic reticulum. The 
Ins(1,4,5)P3.sensitive pool is well established and com- 
prises only a part of the intracellttlar non-mitochondrial 
Ca ~-~ pool [1]. The remainder of the pool, which is 
lns(l,4,5)P3-insensitive, is less well characterized. In a 
number of cell types it has been shown that Ca "-+ can be 
released from part of the Ins(l,4,5)P3-insensitive Ca-'÷- 
pool by a rapid increase in intraeellular f ee Ca "~+ con- 
centration ([Ca-'+]~ [4]. This Ca'-+-induced Ca 2+ release 
(CICR) was initially identified in striated muscle cells 
and later has been demonstrated in a number of non- 
muscle cell types [5-9]. There are at present both 
theoretical grounds [10,11] and experimental evidence 
[12,13] to indicate that CICR may be important in the 
generation of Ca'-+-oscillations. However, CICR is dif- 
ficult to demonstrate directly [4]. Ca 2+ release voked by 
two pharmacological gents, caffeine and ryanodine 
[5,14,15], is taken as evidence for the existence of CICR 
mechanism in cells. Caffeine is required to be used in 
millimolar concentrations and an optimal concentra- 
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tion can often not be used, because of its solubility 
limitations [16,17]. Ryanodine binds very slowly to its 
receptor [ 16,18]. 
Moreover, in many cells Ca-'" release cannot be dem- 
onstrated by caffeine or ryanodine [4,19-21]. It would, 
therefore, be useful to have other pharmacological tools 
that activate CICR in caffeine-insensitive cells [21]. 
The structure and function oi' most cysteine-contain- 
ing proteins critically depend on the oxidation state of 
the protein's sulphydryl groups (SH-groups) [22,23]. 
There is evidence that the receptor-channel protein that 
mediates CICR (ryanodine receptor) in sarcoplasmic 
reticulum contains 'critical' SH-groups [24]. A number 
of sulphydryl reagents that oxidize SH-groups, release 
Ca ~-~ from sarcoplasmic reticulum by opening up the 
CICR channel [25-27]. Thimerosal is a sulphydryl 
reagent hat has been demonstrated to be effective, in 
low micromolar concentrations, in releasing Ca-'" from 
intracellular pools in several non-muscle cell types [28- 
31]. More recently, it has been shown that thimerosal 
specifically sensitizes CICR in unfertilized hamster eggs 
and it has been suggested that this compound can be 
used to demonstrate CICR in caffeine-insensitive cells 
[21]. In this report, we demonstrate that thimerosal 
releases Ca "~+ in permeabilized RINm5F cells, an effect 
potentiated by caffeine, suggesting the existence of 
CICR in insulin-secreting cells. 
2. MATERIALS AND METHODS 
Clonal insulin-secreting RINmSF ~lls veer¢ maintained in culture 
in RPMI 1640 medium supplemented with 10% foetal bovine serum, 
penicillin (100 U/ml) and streptomycin (100/zg/ml), all from Flow 
Laboratories (Scotland). Thimerosai (sodium ethylmereurithiosali- 
c2/late), DL-dithiothreitol (DTT). lns(l.4,5)P~, caffeine, Ruthenium red 
and hcparin were purchased from Sigma (St. Louis, USA). Ryanodine 
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was obtained from Merck Sharp and Dohme (Rahway, NJ, USA). 
Calcium cocktail, containing neutral carrier ETH 1001 was from 
Fluka. All other chemicals were either from Sigma or Merck. 
Cells were detached from culture flasks using trypsin-EDTA; 
washed twice with RPM1 1640 medium and lwicc with a cold no- 
minally Ca2’-free buffer, containing 110 mM KCI. IO mM N&I, 2 
mM KH$O,, I mM MgCI,, 0.5 mg/ml bovina serum albumin and 25 
mM HEPES (pH 7.0 adjustcxi with KOH). Penneabilization was done 
by exposing cells to high-voltage lectrical discharges (six pulses of 3.1 
kV/cm). This treatment resulted in more than 90% permeabilizcd cells, 
as verified by Trypan blue uptake. After permeabiliziltion. cell suspen- 
sion was centrifuged and the pellet was kept on ice until use. 
Eight ,crl of cell pellet was then added to a Plexiglass chamber 
containing 52 yl of incubation buffer. The incubation buffer was the 
same as the washing buffer. supplemented with 2 mM MgATP and 
an ATP.regcnerating system, consisting of 10 mM phosphocreatine 
and 20 U ofcreatine kinasdml. In addition, the incubation bufferalso 
contained mitochondrial inhibitors consisting of 0.2 PM antimycin 
and I flS of oligomycinlml. Additions were made from freshly 
prepared 100 times concentrated stock solutions. Thimerosal was dis- 
solved in water or directly in the buffer. Changes in the ambient free 
Ca” concentration were recorded using a Cn”-selective mini-&t- 
trode, constructed and calibrated esscnlially as described by Tsicn and 
Rink [32]. None of the substances used in the study interfered with 
electrode function. 
3. RESULTS 
Permeabilized RINmSF cells (4.2~10’ cells/ml), in the 
presence of ATP and an ATP-regenerating system, se- 
questered Ca”, resulting in a low steady-state buffer 
Ca’” level. Addition of thimerosal (50 PM, final con- 
centration) resulted in a rise in Ca’+ within 30 s, reach- 
ing a new increased steady state Ca” level in about 4 
min (Fig. la). Thimerosal caused Ca’+ release in a dose- 
dependent manner (Fig. lb). The smallest dose of thi- 
merosal eliciting a detectable rise in Ca” was 25 PM 
and maximum release was obtained by 100 @I. Addi- 
tion of the reducing agent DTT (2 mM, final concentra- 
tion) resulted in immediate onset of re-uptake of CaZ’, 
eventually leading to complete resequestration of the 
ion (Fig. la). 
Heparin binds to the Ins(l,4,5)P, receptor and in- 
hibits lns( I .4,5)P,-induced Ca” release [33-363. When 
added to the buffer in as high a dose as 1000 ,ug/ml, 
heparin did not inhibit Ca2+ release induced by 50 ,uM 
thimerosal (data not shown). When heparin was added 
at the end of completion of thimerosal-induced CR’)+ 
release, there was no re-uptake of the released Ca?’ 
(data not shown). Also, Ruthenium red (30 yM), a sub- 
stance that has been shown to inhibit Cal*-induced CR?+ 
release [37], did not block thimerosal-induced Ca?’ 
release. 
As shown in Fig. 2a, 20 ,KM (a maximal dose) of 
inositol(2,4,5)-trisphosphate (Ins(2,4,5)P,), a non-meta- 
bolizable analogue of Ins(1 ,4,5)P3 was used to empty the 
Ins(l,4,5)P3-sensitive Ca?+ pool. Addition of thimerosal 
at the end of completion of Ins(2,4,5)P,-induced Ca?’ 
release, resulted in further release of Ca?‘. Similarly, 
when thimerosal was added at the end of completion of 
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Fig. I. Effects of thimcrosal and DTT on Ca” release and re-uptake. 
The figure shows Ca!+-electrode traces obtained under conditions 
described in section 2. (a) Release and re-uptake of Ca”, following 
additions, as indicated, of thimerosa) (50pM, final concentration) and 
DTT (2 mM, final concentration). The tract is representative of at 
least three different experiments. (b) Effects of additions of different 
concentrations of thimcrosal on Ca” release. The arrow indicates 
addition of thimerosal (at the final concentrations hown). The figure 
shows the lracc for each concentration Of thimerosaj superimposed 
and is representative of at least three different experiments. 
Ca’+ release by thapsigargin, there was additional 
release of Ca” (Fig. 2b). 
When Ins(l,4,5)Pj (5 yM, final concentration) was 
added after thimerosal-induced Cal+ release was com- 
pleted, marked additional increase in the release of Ca?’ 
was observed (Fig. 3). The magnitude of this 
Ins( 1,4,5)P>-induced Ca2+ release was essentially similar 
to that obtained by Ins(2,4,5)P, in the absence of thimc- 
rosa1 (cf. Fig. 2a). 
Caffeine (2 mM, final concentration) did not induce 
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Fig. 2. Thimerosal releases Ca "~* from the Ins(1,405)Pj.lnsensitive pool. 
Conditions of er.periments were the same a~ described in the legend 
to Fig. I. As indicated, thimerosal (50 tiM, final concentration) we5 
added after empty, in8 the ln~(l,4,5)P~-sensitlve poolby (a) addition of 
lns(2,4,5)P~ (20/zM, final concentration) and (b) thap~isarsin (5/aM, 
final concentration). Each trace is representative of at least 3 different 
experiments. 
Ca-'* release (data not shown). Under our experimental 
conditions the maximal final concentration of caffeine 
that could be achieved by addition from stock solution 
was 2 raM. This was due to difficult:/ in obtaining a 
concentrated nough stock solution of caffeine [16,17]. 
Ryanodine (100 ,uM, final concentration) also did not 
induce Ca -~* release (data not shown). In the presence 
of caffeine (50 mM, final concentration), dissolved i- 
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Fig. 3. Effect of addition of lns(l,4,5)P~ after thimerosal-indueed Ca:" 
rdeas¢ is completed. Conditions of experiments were the same as 
mentioned before. As indicated, tbimerosal (50/aM, final ¢.on~ntra- 
tlon) and lns(l,4,5)P~ (5/aM, final concentration) were added. Each 
trace is reprezentative of at least 5 different experiments. 
rectly in the buffer, addition of thimerosal (50 /aM) 
caused a more pronounced release of Ca 2+ than in the 
absence of  caffeine (eL Fig. 4a and b). 
4. DISCUSSION 
The present study shows that the sulphydryl reagent 
thimerosal, in a dose-dependent manner, releases Ca '-+ 
from an intracellular Ca 2~ pool, in permeabilized 
RINm5F cells. The effect was completely reversed by 
addition of the reducing agent DTT, implying that the 
effect of thimerosal was specifically due to oxidation of 
SH-groups and not due to non-specific and permanent 
damage to the membrane of Ca-~*-storing vesicles. The 
effect of thimerosal in permeabilized RINmSF cells is 
not likely to reflect inhibition of intracellular Ca 2. 
pumps, since the sulphydryl reagent did not alter the 
initial rate of  Ca 2. uptake. There is also evidence from 
other studies that thimerosal, in low concentrations, 
does not inhibit various Ca'-~-pumps [21,29]. 
Although several studies have demonstrated mo- 
bilization of Ca:" from intracellular pools by thime- 
rosal, its mechanism of action is not well understood 
[28-31]. It has been suggested that in non-muscle cells, 
sulphydryl reagents may induce Ca -~* release from the 
Ins(l,4,5)Pa-sensitive pool, by sensitizing the 
Ins(l,4,5)Pa receptor to endogenous levels of 
Ins(l,4,5)Pa [38]. We and others have suggested that, 
under conditions of permeabiiization, RINmSF cells 
also contain basal levels of lns(l,4,5)P3 [36,39]. In this 
study Ca -~* release is unlikely to be due to sensitization 
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of the Ins(l ,4,5)Pj receptor to basal level5 of 
Ins(l,4,5)P,. as has been suggested [38,40], since prior 
presence of heparin in buffer, in as high a concentration 
as 1000 &ml, did not prevent he release. In fact, some 
studies have demonstrated that sulphydryl oxidation of 
the Ins( I ,4,5)P3 receptor rather inhibits Ins(l ,4,5)Ps 
binding [41] and Ins( 1,4,5)Pj-induced Ca’+ release [42]. 
By contrast, other studies have shown that sulphydryl 
oxidation increases the sensitivity of the Ins( I ,4,5)P, 
receptor to the trisphosphate [40]. Interpretation of 
such conflicting data is difficult because of the use of 
different sulphydryl reagents and various cell types in- 
volved. However, since sulphydryl oxidation may also 
sensitize CICR, it cannot be ruled out that the apparent 
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Fig. 4. Caffcinc potentiates thimcrosal-induced Ca’+ release. Condi- 
tions of experiments were the same as mentioned before except hat 
in (a) the incubation buffb, .contained caffeine (50 mM, final con- 
centration). (b) Conlrol experiments done without cafl’eine in buffer. 
Arrows indicate additions of thimerosal (%JflM, final concentration). 
Each of the traces are representative of at least 3 different cxperimcnts. 
increase in sensitivity to low doses of Ins(1,4,5)PJ [40] 
may be confounded by CICR. 
Clearly, thimerosal released Ca” from an 
Ins( 1 ,4,5)PrinsensiGve pool and not from the 
Ins( 1 ,4.5)P3-sensitive pool, in RINmSF cells. This pool 
is not equivalent o mitochondria since mitochondrial 
blockers were routinely used. When the Ins(1 ,4,5)P3- 
sensitive pool was depleted by a supramaximal dose of 
Ins(2,4,5)Pj, addition of thimerosal still released Ca”+, 
which in this case must have been released from an 
Ins( 1 ,4,5)Pj-insensitive pool. In permeabilized 
RINmSF cells, we have demonstrated that thapsigargin 
[43] releases Ca?’ predominantly from an Ins(1,4,5)P,- 
sensitive pool and empties the pool nearly completely 
(Islam and Berggren, unpublished data). Also, under 
these conditions, thimerosal released further Ca’+. The 
question whether thimerosal-induced Ca” release could 
be due to activation of CICR was not addressed in 
earlier studies [28-311, although one study attributed 
the release to an as yet unidentified intracellular Ca?’ 
transport system [29]. Convincing and direct evidence 
that thimcrosal sensitizes CICR has come forth only 
recently [21]. In view of the present findings, it is likely 
that the thimerosal-induced Ca” release from an 
Ins(l,4,5)PJ-insensitive pool in RINmSF cells is due to 
opening up of ClCR channel by SH-group oxidation. 
Evidence that thimerosal-induced Ca?’ release in 
RINmSF cells is due to activation ofCICR is reinforced 
by our demonstration that it can be markedly enhanced 
by caffeine, which is known to activate or sensitize 
CICR. 
The existence of CICR has been inferred from 
caffeine-induced Ca” release in a number of non-mus- 
cle cells [16,4446]. It is possible that ClCR occurs in 
many cell types but is not demonstrable, because of 
their apparent insensitivity to caffeine, as is the case 
with RINmSF cells. These cells may contain a variant 
of the ‘classical’ ryanodine receptor, which mediates 
CICR in sarcoplasmic reticulum. In view of recent 
demonstrations that ClCR may be involved in the 
generation of Ca”-oscillations and wave propagation 
[ 12,131, it is important o clarify its existence in different 
cells and in this context, thimerosal may be an addi- 
tional tool. Although the physiological importance is 
far from being understood, this is the first report 
suggesting the existence of CICR in insulin-secreting 
cells. 
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